Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1985 May;142(5):688–691.

Phenylpropanolamine and cerebral hemorrhage.

J R McDowell, H J LeBlanc
PMCID: PMC1306152  PMID: 4013284

Full text

PDF
688

Images in this article

688Figure 1.
on p.688
688Figure 2.
on p.688
689Figure 3.
on p.689
689Figure 4.
on p.689
690Figure 5.
on p.690

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett W. M. Hazards of the appetite suppressant phenylpropanolamine. Lancet. 1979 Jul 7;2(8132):42–43. doi: 10.1016/s0140-6736(79)90209-5. [DOI] [PubMed] [Google Scholar]
  2. Bernstein E., Diskant B. M. Phenylpropanolamine: a potentially hazardous drug. Ann Emerg Med. 1982 Jun;11(6):311–315. doi: 10.1016/s0196-0644(82)80130-3. [DOI] [PubMed] [Google Scholar]
  3. Blum A. Phenylpropanolamine: an over-the-counter amphetamine? JAMA. 1981 Apr 3;245(13):1346–1347. doi: 10.1001/jama.1981.03310380050029. [DOI] [PubMed] [Google Scholar]
  4. Chouinard G., Ghadirian A. M., Jones B. D. Death attributed to ventricular arrhythmia induced by thioridazine in combination with a single Contac C capsule. Can Med Assoc J. 1978 Oct 7;119(7):729–731. [PMC free article] [PubMed] [Google Scholar]
  5. Citron B. P., Halpern M., McCarron M., Lundberg G. D., McCormick R., Pincus I. J., Tatter D., Haverback B. J. Necrotizing angiitis associated with drug abuse. N Engl J Med. 1970 Nov 5;283(19):1003–1011. doi: 10.1056/NEJM197011052831901. [DOI] [PubMed] [Google Scholar]
  6. Cuthbert M. F., Greenberg M. P., Morley S. W. Cough and cold remedies: a potential danger to patients on monoamine oxidase inhibitors. Br Med J. 1969 Feb 15;1(5641):404–406. doi: 10.1136/bmj.1.5641.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dietz A. J., Jr Amphetamine-like reactions to phenylpropanolamine. JAMA. 1981 Feb 13;245(6):601–602. [PubMed] [Google Scholar]
  8. Frewin D. B., Leonello P. P., Frewin M. E. Hypertension after ingestion of Trimolets. Med J Aust. 1978 Nov 4;2(10):497–498. doi: 10.5694/j.1326-5377.1978.tb131671.x. [DOI] [PubMed] [Google Scholar]
  9. Horowitz J. D., Lang W. J., Howes L. G., Fennessy M. R., Christophidis N., Rand M. J., Louis W. J. Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations. Lancet. 1980 Jan 12;1(8159):60–61. doi: 10.1016/s0140-6736(80)90490-0. [DOI] [PubMed] [Google Scholar]
  10. Kessler J. T., Jortner B. S., Adapon B. D. Cerebral vasculitis in a drug abuser. J Clin Psychiatry. 1978 Jun;39(6):559–564. [PubMed] [Google Scholar]
  11. King J. Hypertension and cerebral haemorrhage after trimolets ingestion. Med J Aust. 1979 Sep 8;2(5):258–258. doi: 10.5694/j.1326-5377.1979.tb127123.x. [DOI] [PubMed] [Google Scholar]
  12. Lee K. Y., Beilin L. J., Vandongen R. Severe hypertension after ingestion of an appetite suppressant (phenylpropanolamine) with indomethacin. Lancet. 1979 May 26;1(8126):1110–1111. doi: 10.1016/s0140-6736(79)91791-4. [DOI] [PubMed] [Google Scholar]
  13. Margolis M. T., Newton T. H. Methamphetamine ("speed") arteritis. Neuroradiology. 1971 Aug;2(3):179–182. doi: 10.1007/BF00335049. [DOI] [PubMed] [Google Scholar]
  14. Mueller S. M. Neurologic complications of phenylpropanolamine use. Neurology. 1983 May;33(5):650–652. doi: 10.1212/wnl.33.5.650. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES